• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Establishment of a producer cell line for adeno-associated virus vector using a novel system regulating nuclear protein

Research Project

Project/Area Number 10557035
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Virology
Research InstitutionJichi Medical School

Principal Investigator

URABE Masashi  Jichi Medical School, Faculty of Medicine, Reaearch Associate, 医学部, 助手 (40213516)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Tohru  Sankyo Biomedical Laboratories, Senior Scientist, バイオメディカル研究所, 副主任研究員
KUME Akihiro  Jichi Medical School, Faculty of Medicine, Assistant Professor, 医学部, 講師 (10264293)
OZAWA Keiya  Jichi Medical School, Faculty of Medicine, Professor, 医学部, 教授 (30137707)
Project Period (FY) 1998 – 1999
Keywordsadeno-associated virus vector / packaging cells / nuclear proteins / Rep protein / protease / Clover yellow vein virus
Research Abstract

We explored a novel approach to the functional regulation of nuclear proteins; altering their subcellular localization. To anchor a nuclear protein, β-galactosidase with the nuclear localization signal of SV40 (nβ-gal), within the cytoplasm, it was fused to the transmembrane domain of granulocyte colony-stimulating factor receptor(G-CSFR). To liberate the nβ-gal portion from the fusion protein, we used a protease derived from clover yellow vein virus, Nia protease, whose recognition sequence was inserted between the G-CSFR and nβ-gal. Western analysis showed that the chimeric protein was cleaved in the presence of the protease in 293 cells and that the fusion protein without the recognition sequence remained intact. This chimeric protein was localized exclusively in the cytoplasm as visualized by X-gal staining and immunofluorescent staining using an anti-P-gal antibody. When expressed together with the Nia, β-gal was predominantly detected in the nuclei. Moreover, we isolated 293-cell clones constitutively expressing the Nia, indicating this protease is not cytotoxic. Based on these results, we constructed a dicistronic plasmid expressing an Rep protein fused with G-CSFR driven by the p5 promoter and the blasticidin S resistance gene under the translational control of the encephalomyocarditis virus internal ribosome entry site (IRES). Following transfection of 293 cells with this plasmid and the selection with blasticidin S, we isolated cell clones that could produce recombinant AAV after transfection with small Rep/Cap plasmid, Adenovirus helper plasmid, and Nia plasmid. The yield of rAAV was increased 10-fold when the Nia plasmid was cotransfected (about 105 particles/10-cm dish). However, the titer of rAAV produced by these cell lines gradually decreased as they were passaged. These results indicated the presence of a leaky nuclear transport of the chimeric protein even in the absence of the Nia protease.

  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] Shen, Y.: "Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for therapy of Parkinson's disease"Hum. Hege. Ther.. 11. 1509-1519 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ogasawara, Y.: "Highly regulated expression of adeno-associated virus large Rep proteins in stable 293 cell line using the Cre/loxP switching system"J. Gen. Virol.. 80. 2477-2480 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Urabe, M.: "A switching system regulating subcellular localization of nuclear proteins using a viral protease"Biochem. Biophys. Res. Commun.. 266. 92-96 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Urabe, M.: "DNA/Calcium phosphate precipitates mixed with medium are stable and maintain high transfection efficiency."Anal. Biochem.. 278. 91-92 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Urabe, M.: "Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 proteins"J. Virol.. 73. 2682-2693 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimazaki, K.: "Adeno-associated virus vectro-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death."Gene Ther.. 7. 1244-1249 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] KUME, A. et al.: "Hematopoietic stem cell gene therapy: a current overview."Int J Hematol. 69. 227-233 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] KUME, A., et al.: "A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells."Biochem Biophys Res Commun. 260. 9-12 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] KUME, A. et al.: "Long-term tracking of murine hematopoietic cells transduce with a bicistronic retrovirus containing CD24 and EGFP genes."Gene Ther. 7. 1193-1199 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] MATSUDA, K. M. et al: "Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy."Gene Ther. 6. 1038-1044 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] OGASAWARA, Y. et al.: "Highly regulated expression of adeno-associated virus large Rep proteins in stable 293 cell lines using the Cre/loxP switching system."J Gen Virol. 80. 2477-2480 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] OGASAWARA, Y. et al: "Efficient production of adeno-associated virus vectors using split-type helper plasmids."Jpn J Cancer Res. 90. 476-483 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] SHEN, Y. et al.: "Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease."Hum Gene Ther. 11. 1509-1519 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] SHIMAZAKI, K. et al.: "Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death."Gene Ther. 7. 1244-1249 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] SHIMPO, M. et al: "Gene transfer into rat renal cells using adeno-associated virus vectors."Am J Nephrol. 20. 242-247 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] URABE M.et al.: "Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein."J Virol. 73. 2682-2693 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] URABE.M.et al.: "A switching system regulating subcellular localization of nuclear proteins using a viral protease."Biochem Biophys Res Commun. 266. 92-96 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] URABE.M.et al.: "DNA/Calcium phosphate precipitates mixed with medium are stable and maintain high transfection efficiency."Anal Biochem. 278. 91-92 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] XU, R. et aL.: "A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells."J Gene Med. 1. 236-244 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi